EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Does aspirin worsen Crohn’s disease outcomes? A multicenter propensity-matched cohort study

Kojo-Frimpong B Awuah iD, Komlan Guedze iD, Somtochukwu Onwuzo iD, Chidera Onwuzo, Rashid Abdel-Razeq, Kingsley Ozongwu, Tyrell Daniel

Baylor University Medical Center Proceedings · 04.05.2026 · 39 (3) · 396-400

DOI: 10.1080/08998280.2026.2633485 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Baylor University Medical Center Proceedings, online erschienen am 26.02.2026. Verfasst von Kojo-Frimpong B Awuah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Crohn Disease, Aspirin, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseAspirinAnti-Inflammatory Agents, Non-SteroidalHumansFemaleMaleMiddle AgedAdultCohort StudiesPropensity Score

Stichwörter der Autor:innen

AspirinCrohn’s diseaseexacerbationinflammatory bowel diseasetoxic megacolon

Substanzen

AspirinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Internal Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Department of Internal Medicine, Franciscan Health, Olympia Fields, Illinois, USA.
  • Division of Gastroenterology and Hepatology, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Department of Internal Medicine, SUNY Upstate, Syracuse, New York, USA.
  • Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Internal Medicine, Sentara Northern Virginia Medical Center, Woodbridge, Virginia, USA.

ORCID-Profile: Kojo-Frimpong B Awuah, Komlan Guedze, Somtochukwu Onwuzo

Zitieren

APA

Awuah, K. B., Guedze, K., Onwuzo, S., Onwuzo, C., Abdel-Razeq, R., Ozongwu, K., & Daniel, T. (2026). Does aspirin worsen Crohn’s disease outcomes? A multicenter propensity-matched cohort study. Baylor University Medical Center Proceedings, 39(3), 396-400. https://doi.org/10.1080/08998280.2026.2633485

Vancouver

Awuah KB, Guedze K, Onwuzo S, Onwuzo C, Abdel-Razeq R, Ozongwu K, et al. Does aspirin worsen Crohn’s disease outcomes? A multicenter propensity-matched cohort study. Baylor University Medical Center Proceedings. 2026;39(3):396-400. doi:10.1080/08998280.2026.2633485

BibTeX
@article{Awuah2026,
  author = {Awuah, Kojo-Frimpong B and Guedze, Komlan and Onwuzo, Somtochukwu and Onwuzo, Chidera and Abdel-Razeq, Rashid and Ozongwu, Kingsley and Daniel, Tyrell},
  title = {Does aspirin worsen Crohn’s disease outcomes? A multicenter propensity-matched cohort study},
  journal = {Baylor University Medical Center Proceedings},
  year = {2026},
  volume = {39},
  number = {3},
  pages = {396--400},
  doi = {10.1080/08998280.2026.2633485}
}
Kostenlos starten →